Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jul 15, 2026; 18(7): 119170
Published online Jul 15, 2026. doi: 10.4251/wjgo.119170
Published online Jul 15, 2026. doi: 10.4251/wjgo.119170
Table 4 Association between anxiety and depression and adverse reactions during chemotherapy, n (%)
| Symptoms | Group | Normal group (n = 80) | Anxiety-depression group (n = 73) | Statistic | P value |
| Gastrointestinal reactions | 0 | 13 (16.25) | 4 (5.48) | 7.69 | 0.021 |
| I/II | 60 (75.00) | 54 (73.97) | |||
| III-IV | 7 (8.75) | 15 (20.55) | |||
| Myelosuppression | 0 | 14 (17.50) | 7 (9.59) | 3.49 | 0.175 |
| I/II | 62 (77.50) | 58 (79.45) | |||
| III-IV | 4 (5.00) | 8 (10.96) | |||
| Hematological toxicity | 0 | 16 (20.00) | 11 (15.07) | 1.94 | 0.380 |
| I/II | 58 (72.50) | 52 (71.23) | |||
| III-IV | 6 (7.50) | 10 (13.70) | |||
| Neurotoxicity | 0 | 19 (23.75) | 9 (12.33) | 4.49 | 0.106 |
| I/II | 53 (66.25) | 51 (69.86) | |||
| III-IV | 8 (10.00) | 13 (17.81) |
- Citation: Cui BY, Zhang Z. Impact of anxiety and depression on quality of life in gastric cancer patients receiving SOX neoadjuvant chemotherapy. World J Gastrointest Oncol 2026; 18(7): 119170
- URL: https://www.wjgnet.com/1948-5204/full/v18/i7/119170.htm
- DOI: https://dx.doi.org/10.4251/wjgo.119170